GUNA Collagen
Explore our existing anatomical treatment gallery and collagen information.
ADVANCED MUSCULOSKELETAL CARE
Our Treatments
Explore injectable and non-invasive treatment options for joint health, mobility and musculoskeletal care. Select a treatment below to discover more.
Every treatment begins with a clinical assessment. Suitability, expected benefits, limitations and available evidence should be discussed with your practitioner.
✦ / REGEN TREATMENT SELECTOR
Explore the treatments below, or choose a category to see more.
Cingal
Hyaluronic acid and corticosteroid in one knee injection.
Biolevox
Three formulations grouped together: HA One, HA and HA Tendon.
KiOmedineVSone
Mushroom-derived CM-chitosan injection for symptomatic knee osteoarthritis.
Shockwave + EMTT
Two different technologies for selected musculoskeletal conditions.
Treatment Prices
Explore session and injection prices, treatment courses and combination options.
CLEAR, UPFRONT INFORMATION
Treatment Prices
Explore our indicative treatment fees. Your recommended treatment plan and final cost will be discussed during your consultation.
Shockwave Therapy
£130 per session
A typical course involves 4–6 sessions, depending on your assessment.
GUNA Collagen
£165 per injection
A typical course involves approximately 5–10 injections, usually administered weekly, where clinically appropriate.
Hyaluronic Acid (HA)
Single joint£400
Two joints£540
Injection treatment subject to clinical assessment and product suitability.
KiOmedine
One joint£700
Two joints£1,250
Injection treatment subject to clinical assessment and product suitability.
Combination treatments
Shockwave therapy may be combined with GUNA collagen, hyaluronic acid (HA) or KiOmedine where appropriate. Your clinician will determine the recommended approach after your initial consultation.
Spinal degeneration & disc pain
Assessment and treatment options are available for spinal degeneration and disc-related pain. Prices are determined after the initial consultation.
Prices are indicative and should be confirmed with the clinic. Treatment suitability, frequency, combinations and outcomes depend on individual clinical assessment.
Book a consultation →TARGETED MUSCULOSKELETAL CARE
GUNA Collagen
Explore treatment areas, clinical assessment and personalised rehabilitation.
GUNA collagen-based injectable products may be considered for selected musculoskeletal presentations following an individual clinical assessment. Chris can explain the available evidence, risks, alternatives and whether treatment is appropriate.
Explore GUNA Collagen treatments →
01 / ASSESSMENT
Understanding your condition
Symptoms, movement and treatment history are reviewed before deciding on suitable options.
02 / TREATMENT
GUNA collagen approach
Products, intended uses and supporting evidence should be discussed with the treating clinician.
03 / RECOVERY
Rehabilitation & follow-up
Recovery advice and any exercise or shockwave programme are tailored to individual needs.
The illustrations are educational. Treatment suitability and outcomes require individual clinical assessment.
INJECTABLE TREATMENTS
Cingal
Hyaluronic acid and corticosteroid treatment for selected patients with knee osteoarthritis.
Cingal combines hyaluronic acid with triamcinolone hexacetonide in a single intra-articular injection. The components are intended to support joint lubrication and manage inflammation respectively. Treatment suitability and outcomes vary between patients.
The knee joint
The knee relies on cartilage, synovial fluid and surrounding tissues for comfortable movement.
Osteoarthritis
Osteoarthritis can involve cartilage changes, pain, stiffness and reduced mobility.
How Cingal works
The corticosteroid addresses inflammation, while hyaluronic acid provides viscosupplementation.
Treatment process
Assessment, discussion of risks and alternatives, injection by a qualified clinician, and aftercare.
Joint symptom managementSupport for mobilitySingle-injection formulationNon-surgical option
Illustrations are educational, not procedural guidance. Benefits are not guaranteed. A clinician should explain suitability, contraindications, possible adverse effects and available alternatives before treatment.
INJECTABLE TREATMENT FAMILY
Biolevox
Four hyaluronic acid formulations. Explore the options with your clinician.
Biolevox HA One, HA, HA Tendon and HA Mini have different intended applications. Chris can discuss product information, availability and suitability following an individual clinical assessment.
01 / JOINTS
Biolevox HA One
A hyaluronic acid formulation intended for a single-injection approach in appropriate joints, subject to clinical assessment and product instructions.
Joint lubrication
Single-injection formulation
Movement support
Clinical assessment
02 / JOINTS
Biolevox HA
A hyaluronic acid formulation that may be administered as a course of injections, depending on the individual and the product instructions.
Joint lubrication
Injection schedule by assessment
Joint function
Individual suitability
03 / TENDONS
Biolevox HA Tendon
A formulation intended for selected tendon-related applications. Suitability and the treatment approach require an individual clinical assessment.
Tendon-focused care
Tissue hydration
Function and mobility
Clinical assessment
04 / SMALL JOINTS
Biolevox HA Mini
A smaller-volume hyaluronic acid formulation for selected small-joint applications. Product indications, dosage and suitability must be confirmed against the manufacturer’s instructions.
Small-joint focus
Product verification
Individual suitability
Clinical assessment
Artwork is illustrative and does not depict verified product packaging or a recommended injection technique. Product availability, indications and clinical claims require confirmation with Chris before publication.
INJECTABLE TREATMENTS
KiOmedineVSone
A different approach to knee osteoarthritis symptom management.
KiOmedineVSone is a single intra-articular injection containing mushroom-derived carboxymethyl-chitosan (CM-chitosan). Unlike some other joint injections, it is not hyaluronic acid.
NON-ANIMAL DERIVED CM-CHITOSAN
01 / UNDERSTANDING THE CONDITION
Knee osteoarthritis
Osteoarthritis may cause knee pain, stiffness and reduced mobility. An individual assessment helps determine suitable options.
02 / THE FORMULATION
CM-chitosan technology
The injectable formulation uses a mushroom-derived polymer. It is distinct from hyaluronic acid-based viscosupplements.
03 / PATIENT JOURNEY
Assessment & aftercare
Chris can explain potential benefits, uncertainties, contraindications, alternatives and aftercare before any treatment.
THE EVIDENCE
What does research tell us?
Clinical studies have explored pain and function outcomes in knee osteoarthritis. A 2025 pilot study found improvements in both the KiOmedineVSone and comparator groups, without a statistically significant between-group pain difference at 12 months.
Read the PIONEER study ↗Anatomical artwork is illustrative, adapted from existing site illustrations, and does not depict KiOmedine product packaging or a recommended injection technique. Claims, product availability and suitability require clinical review by Chris before publication. No treatment outcome is guaranteed.
NON-INVASIVE MUSCULOSKELETAL CARE
Shockwave + EMTT
Two different technologies. A personalised approach to treatment.
Focused shockwave therapy delivers acoustic energy to targeted tissue. Extracorporeal Magnetotransduction Therapy (EMTT) uses pulsed electromagnetic fields. Depending on your condition and clinical assessment, Chris can discuss whether either treatment may be appropriate.
01 / FOCUSED SHOCKWAVE
Targeted acoustic energy
Focused acoustic waves are delivered to a selected area. Treatment choice and expected outcomes depend on the diagnosis and available evidence.
02 / EMTT
Electromagnetic therapy
EMTT applies pulsed electromagnetic fields. Evidence for its effectiveness varies across musculoskeletal conditions, and it may not suit everyone.
03 / INDIVIDUAL PLAN
Assessment & rehabilitation
Chris can discuss whether one or both therapies have a role alongside exercise, rehabilitation or other care. Combining treatments does not guarantee better results.
Artwork is illustrative and does not depict verified treatment devices, device placement or clinical technique. Treatment availability, contraindications, evidence and equipment specifications must be confirmed with Chris before publication.